Literature DB >> 2566674

A simple and rapid liquid chromatographic method for the determination of major metabolites of sulfasalazine in biological fluids.

V S Chungi1, G S Rekhi, L Shargel.   

Abstract

A simple and rapid assay for quantitation of sulfasalazine metabolites in rat urine and plasma was developed using high-performance liquid chromatography (HPLC). The method involves dilution of urine or plasma samples (0.1 mL) with methanol for protein precipitation, followed by mixing and centrifugation at 10,000 x g. Chromatography was accomplished with a reversed-phase ODS C-18 column (5 mu; 4.6 x 250 mm). The mobile phase consisted of 20% methanol in 5.0 mM phosphate buffer (pH 6.0), with 0.5 mM tetrabutylammonium chloride as an ion-pairing agent. The flow rate was 1.7 mL/min. An injection volume of 30 microL was used and the metabolites were quantitated by an ultraviolet detector at 254 nm. Benzamide was used as the internal standard. This method is linear in the range of 0.5 to 25 micrograms/mL for 5-aminosalicylic acid (5-ASA), acetylsulfapyridine (Ac-SP), and acetyl-5-aminosalicylic acid (Ac-5-ASA), and from 0.25 to 25 micrograms/mL for sulfapyridine (SP). The percent relative standard deviation ranged from 1 to 7.9% for the metabolite standard curves and precision studies. The limit of detection for 5-ASA, Ac-SP, and Ac-5-ASA is 100 ng/mL, and for SP is 50 ng/mL, in both urine and plasma. This method is rapid, precise, and accurate, and has been used to determine sulfasalazine metabolites in individual rat plasma and urine samples following an oral dose of 60 mg/kg of sulfasalazine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566674     DOI: 10.1002/jps.2600780313

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates.

Authors:  Mei-Juan Zou; Gang Cheng; Hirokazu Okamoto; Xiu-Hua Hao; Feng An; Fu-De Cui; Kazumi Danjo
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

2.  Pharmacokinetics of sulfasalazine metabolites in rats following concomitant oral administration of riboflavin.

Authors:  V S Chungi; L W Dittert; L Shargel
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

3.  Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea.

Authors:  D Sharpstone; P Neild; R Crane; C Taylor; C Hodgson; R Sherwood; B Gazzard; I Bjarnason
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease.

Authors:  K Teahon; S Somasundaram; T Smith; I Menzies; I Bjarnason
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

5.  Development of An HPLC Method for the Determination of Mesalazine in Human Plasma by Fluorimetric Derivatization and Application to A Prototype Pharmacokinetic Study.

Authors:  Burhan Ceylan; Evrim Kepekci Tekkeli; Cem Önal
Journal:  J Fluoresc       Date:  2021-11-19       Impact factor: 2.217

6.  Amino acid derivatives of 5-ASA as novel prodrugs for intestinal drug delivery.

Authors:  C Clerici; G Gentili; E Boschetti; C Santucci; A G Aburbeh; B Natalini; R Pellicciari; A Morelli
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

7.  Degradation Study on Sulfasalazine and a Validated HPLC-UV Method for its Stability Testing.

Authors:  Balraj Saini; Gulshan Bansal
Journal:  Sci Pharm       Date:  2014-01-12

8.  The effect of bariatric surgery on intestinal absorption and transit time.

Authors:  Kirstin A Carswell; Royce P Vincent; Ajay P Belgaumkar; Roy A Sherwood; Stephanie A Amiel; Ameet G Patel; Carel W le Roux
Journal:  Obes Surg       Date:  2014-05       Impact factor: 4.129

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.